Quantitative changes of melanoma-associated antigens as a biomarker for targeted therapy response

被引：1
|
作者：
Arenberger, Petr [1 ,2 ]
Fialova, Alena [1 ,2 ]
Gkalpakiotis, Spyridon [1 ,2 ]
Pavlikova, Andrea [3 ]
Arenbergerova, Monika [1 ,2 ]
机构：
[1] Charles Univ Prague, Dept Dermatovenereol, Fac Med 3, Srobarova 50, Prague 10034 10, Czech Republic
[2] Fac Hosp Kralovske Vinohrady, Srobarova 50, Prague 10034 10, Czech Republic
[3] Fac Hosp Kralovske Vinohrady, Inst Lab Diagnost, Prague, Czech Republic
来源：
EXPERIMENTAL DERMATOLOGY | 2016年 / 25卷 / 09期
关键词：
biomarker; circulating tumor cell; melanoma; targeted therapy; CIRCULATING TUMOR-CELLS; SURVIVAL; PCR;
D O I：
10.1111/exd.12947
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：727 / 729
页数：3
相关论文
共 50 条
  • [21] Panniculitis does not predict clinical response in patients with advanced melanoma under targeted therapy
    Marie Piroth
    Thomas Goronflot
    Romain Samaran
    Emilie Varey
    Alexandra Poinas
    Amir Khammari
    Brigitte Dreno
    European Journal of Dermatology, 2023, 33 : 126 - 136
  • [22] Cessation of targeted therapy after a complete response in BRAF-mutant advanced melanoma: a case series
    Carlino, Matteo S.
    Vanella, Vito
    Girgis, Christina
    Giannarelli, Diana
    Guminski, Alex
    Festino, Lucia
    Kefford, Richard F.
    Menzies, Alexander M.
    Long, Georgina V.
    Ascierto, Paolo A.
    BRITISH JOURNAL OF CANCER, 2016, 115 (11) : 1280 - 1284
  • [23] Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy
    Wellbrock, Claudia
    Arozarena, Imanol
    PIGMENT CELL & MELANOMA RESEARCH, 2015, 28 (04) : 390 - 406
  • [24] Common toxicities associated with immune checkpoint inhibitors and targeted therapy in the treatment of melanoma: A systematic scoping review
    Egeler, Mees D.
    van Leeuwen, Marieke
    Fraterman, Itske
    van den Heuvel, Noelle M. J.
    Boekhout, Annelies H.
    Lai-Kwon, Julia
    Wilthagen, Erica A.
    Eriksson, Hanna
    Haanen, John B.
    Wilgenhof, Sofie
    Ascierto, Paolo A.
    van Akkooi, Alexander C. J.
    van de Poll-Franse, Lonneke V.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 183
  • [25] Development of a biomarker signature associated with anoikis to predict prognosis and immunotherapy response in melanoma
    Wu, Zhixuan
    Zhang, Rongrong
    Bao, Jingxia
    Yin, Mengqi
    Wang, Xiaowu
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (06)
  • [26] Targeted Quantitative Profiling of GTP-Binding Proteins Associated with Metastasis of Melanoma Cells
    Cai, Rong
    Bade, David
    Liu, Xiaochuan
    Huang, Ming
    Qi, Tianyu F.
    Wang, Yinsheng
    JOURNAL OF PROTEOME RESEARCH, 2021, 20 (11) : 5189 - 5195
  • [27] Prognostic Factors Associated with Complete Response with Systemic Therapy in Patients with Stage IV Melanoma
    Bedikian, A. Y.
    Johnson, M. M.
    Warneke, C. L.
    Papadopoulos, N. E.
    Kim, K.
    Hwu, W. -J.
    McIntyre, S.
    Rohlfs, M.
    Homsi, J.
    Hwu, P.
    PROCEEDINGS OF THE XXTH INTERNATIONAL PIGMENT CELL CONFERENCE - IPCC AND VTH INTERNATIONAL MELANOMA RESEARCH CONGRESS - IMRC, 2008, : 161 - 170
  • [28] Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy
    Templeton, Arnoud J.
    Knox, Jennifer J.
    Lin, Xun
    Simantov, Ronit
    Xie, Wanling
    Lawrence, Nicola
    Broom, Reuben
    Fay, Andre P.
    Rini, Brian
    Donskov, Frede
    Bjarnason, Georg A.
    Smoragiewicz, Martin
    Kollmannsberger, Christian
    Kanesvaran, Ravindran
    Alimohamed, Nimira
    Hermanns, Thomas
    Wells, J. Connor
    Amir, Eitan
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    EUROPEAN UROLOGY, 2016, 70 (02) : 358 - 364
  • [29] Economic Burden of Adverse Events Associated with Immunotherapy and Targeted Therapy for Metastatic Melanoma in the Elderly
    Ghate, Sameer R.
    Li, Zhiyi
    Tang, Jackson
    Nakasato, Antonio Reis
    AMERICAN HEALTH AND DRUG BENEFITS, 2018, 11 (07) : 334 - 343
  • [30] Regression of nevi, vitiligo-like depigmentation and halo phenomenon may indicate response to immunotherapy and targeted therapy in melanoma
    Farinazzo, Eleonora
    Zelin, Enrico
    Agozzino, Marina
    Papa, Giovanni
    Pizzichetta, Maria Antonietta
    Di Meo, Nicola
    Zalaudek, Iris
    MELANOMA RESEARCH, 2021, 31 (06) : 582 - 585
12345